1 uct Glybera for the treatment of lipoprotein lipase deficiency.

2 s in children and adults with lysosomal acid lipase deficiency.

3 AV1) vector for the treatment of lipoprotein lipase deficiency.

4                             Monoacylglycerol lipase deficiency affects diet-induced obesity, fat abso

5 y in children and adults with lysosomal acid lipase deficiency, an underappreciated cause of cirrhosi

6 tified mutations in LMF1 that cause combined lipase deficiency and hypertriglyceridemia in humans.

7 y's disease, Pompe's disease, lysosomal acid lipase deficiency, and five types of mucopolysaccharidos

8 l growth and emphysema during lysosomal acid lipase deficiency are partially caused by peroxisome pro

9 asts from patients with WD (a lysosomal acid lipase deficiency characterized by excessive lipid accum

10                   Mice carrying the combined lipase deficiency (cld) mutation show severe hypertrigly

11 , such as HIV, lipodystrophy, lysosomal acid lipase deficiency, familial hypobetalipoproteinemia, and

12 saturation in contrast to the lysosomal acid lipase deficiency found in Wolman disease.

13 e been approved for treatment of lipoprotein lipase deficiency in Europe.

14                               Lysosomal acid lipase deficiency is a rare, autosomal recessive conditi

15                               Lysosomal acid lipase deficiency (LAL-D) is caused by mutations in the

16 n's disease, a severe form of lysosomal acid lipase deficiency, leads to pathologic lipid accumulatio

17 al heart dysfunction in adipose triglyceride lipase deficiency, Plin5-Tg mice do not develop heart dy

18                               Lysosomal acid lipase deficiency-which can be diagnosed using dry blood

19 terious mutation in LMF1 also shows combined lipase deficiency with concomitant hypertriglyceridemia